iRegene Achieves Dual Global Firsts in Parkinson’s, MSA Trials
23 Feb 2026 //
PR NEWSWIRE BIO
iRegene Secures Historic FDA RMAT for Parkinson’s iPSC Therapy
20 Jan 2026 //
FIERCE BIOTECH
Iregene Unleashes Scalable Technology For Cell Therapy
27 Oct 2025 //
FIERCE BIOTECH
Iregene Therapeutics Reveals Positive Nouvneu001 Phase I Results
13 Oct 2025 //
PR NEWSWIRE

Market Place
Sourcing Support